Go Pro
→ Trump Takes Emergency Action - Plus Elon Musk's New Venture (From Altimetry) (Ad)tc pixel Free ZEPP Stock Alerts

Zepp Health (ZEPP) Financials

Zepp Health logo
$5.14 -0.23 (-4.23%)
Closing price 07/16/2026 03:58 PM Eastern
Extended Trading
$5.17 +0.03 (+0.52%)
As of 04:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Zepp Health

Annual Income Statements for Zepp Health

This table shows Zepp Health's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -9.33 -1.74 7.08 17 82 35 22 -43 -31 -76 -40
Consolidated Net Income / (Loss)		 -5.76 3.43 26 49 82 35 21 -43 -31 -76 -40
Net Income / (Loss) Continuing Operations		 -5.76 3.43 26 49 82 35 21 -43 -31 -76 -40
Total Pre-Tax Income 		-5.90 4.14 29 56 94 41 17 -56 -35 -58 -35
Total Operating Income		 -6.11 1.92 28 53 87 27 15 -62 -30 -47 -29
Total Gross Profit		 17 40 76 137 211 205 205 119 92 70 99
Total Revenue		 136 223 314 531 835 989 981 614 353 183 259
Operating Revenue		 136 223 314 531 835 989 981 614 353 183 259
Total Cost of Revenue		 120 184 238 394 624 785 776 495 261 112 160
Operating Cost of Revenue		 120 184 238 394 624 785 776 495 261 112 160
Total Operating Expenses		 23 38 48 84 124 178 190 181 123 117 128
Selling, General & Admin Expense		 11 15 18 31 36 40 41 35 27 25 29
Marketing Expense		 2.92 3.99 6.76 14 26 55 69 68 45 46 54
Research & Development Expense		 9.37 19 24 38 62 83 81 77 52 46 45
Total Other Income / (Expense), net		 0.21 2.22 1.52 3.04 6.59 14 2.00 5.96 -4.18 -11 -6.23
Interest Expense		 -0.04 -0.11 -0.46 -1.69 0.00 3.48 7.04 8.44 6.75 5.55 5.70
Interest & Investment Income		 - 0.00 0.00 0.04 4.43 18 2.62 7.87 3.30 5.68 1.60
Other Income / (Expense), net		 0.17 2.11 1.06 1.31 2.15 -0.14 6.42 6.54 -0.73 -11 -2.14
Income Tax Expense		 -0.14 0.44 4.24 7.57 11 4.79 1.69 -9.87 -2.43 14 2.54
Other Gains / (Losses), net		 0.00 -0.26 0.43 0.25 -0.16 -0.73 6.44 2.68 1.11 -4.21 -2.07
Net Income / (Loss) Attributable to Noncontrolling Interest		 0.00 0.00 12 1.23 0.09 0.15 -0.13 -0.10 -0.07 -0.08 0.00
Basic Earnings per Share		 ($1.22) ($0.22) $0.68 $0.54 $2.35 $0.92 $0.55 ($0.18) ($0.13) ($0.29) ($0.16)
Weighted Average Basic Shares Outstanding		 50.04M 55.61M 67.78M 211.87M 243.65M 248.47M 252.17M 246.28M 243.14M 258.88M 254.43M
Diluted Earnings per Share		 ($1.22) ($0.22) $0.65 $0.51 $2.24 $0.88 $0.52 ($0.18) ($0.13) ($0.29) ($0.16)
Weighted Average Diluted Shares Outstanding		 50.04M 55.61M 76.29M 225.03M 255.96M 260.35M 264.37M 246.28M 243.14M 258.88M 254.43M
Weighted Average Basic & Diluted Shares Outstanding		 - - 280.21M 241.68M 247.52M 250.15M 251.20M 245.34M 240.83M 231.98M 234.89M

Quarterly Income Statements for Zepp Health

No quarterly income statements for Zepp Health are available.

Annual Cash Flow Statements for Zepp Health

This table details how cash moves in and out of Zepp Health's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 31 -10 34 149 49 79 -118 -81 8.65 -25 0.62
Net Cash From Operating Activities		 -1.03 2.48 37 103 61 24 -36 -117 43 -24 -26
Net Cash From Continuing Operating Activities		 -1.03 2.48 37 103 61 24 -36 -117 43 -24 -26
Net Income / (Loss) Continuing Operations		 -5.76 3.43 26 49 82 35 21 -43 -31 -76 -40
Consolidated Net Income / (Loss)		 -5.76 3.43 26 49 82 35 21 -43 -31 -76 -40
Depreciation Expense		 0.04 0.34 0.54 0.90 2.47 4.17 8.14 8.71 7.69 5.02 4.54
Non-Cash Adjustments To Reconcile Net Income		 8.52 9.07 10 22 20 17 36 14 13 16 33
Changes in Operating Assets and Liabilities, net		 -3.84 -10 0.10 31 -44 -33 -102 -96 53 31 -23
Net Cash From Investing Activities		 -0.75 -14 -5.97 -47 -16 -32 -168 -6.24 7.73 -1.58 1.48
Net Cash From Continuing Investing Activities		 -0.75 -14 -5.97 -47 -16 -32 -168 -6.24 7.73 -1.58 1.48
Purchase of Property, Plant & Equipment		 -0.44 -1.47 -3.29 -2.49 -4.92 -13 -7.23 -1.21 -1.60 -1.40 -0.52
Acquisitions		 0.00 -0.18 0.34 -7.57 -1.70 -4.30 -1.10 -0.27 -0.08 -0.09 -0.27
Purchase of Investments		 -0.30 -13 -4.62 -23 -26 -13 -168 -6.62 -1.69 -7.00 0.00
Sale of Property, Plant & Equipment		 0.00 0.00 0.03 - 0.00 0.00 0.40 0.00 1.60 0.70 0.12
Divestitures		 - - - - 0.00 -1.18 3.14 0.06 3.56 1.05 0.47
Sale and/or Maturity of Investments		 0.00 0.00 3.86 42 15 32 3.94 1.80 5.93 5.16 1.67
Net Cash From Financing Activities		 33 1.44 3.08 93 3.68 87 86 42 -42 0.48 25
Net Cash From Continuing Financing Activities		 33 1.44 3.08 93 3.68 87 86 42 -42 0.48 25
Repayment of Debt		 0.00 0.00 -1.53 -4.84 -2.87 -99 -150 -108 -162 -75 -170
Repurchase of Common Equity		 -2.96 0.00 0.00 -1.19 0.00 0.00 -2.16 -8.16 -2.77 -2.28 -1.24
Payment of Dividends		 - - 0.00 0.00 -0.65 0.00 0.00 -6.31 0.00 -0.71 -1.07
Issuance of Debt		 0.00 1.43 4.60 2.91 0.00 186 231 171 123 79 197
Cash Interest Paid		 0.00 0.00 0.31 0.19 0.04 2.29 7.40 8.30 6.27 0.09 1.24

Quarterly Cash Flow Statements for Zepp Health

No quarterly cash flow statements for Zepp Health are available.

Annual Balance Sheets for Zepp Health

This table presents Zepp Health's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 140 225 474 743 908 955 764 636 529 565
Total Current Assets		 123 199 416 631 743 617 429 317 252 294
Cash & Equivalents		 22 56 210 259 350 230 129 134 91 57
Restricted Cash		 0.00 0.49 1.46 0.13 0.37 6.44 13 6.80 20 56
Short-Term Investments		 1.32 2.11 7.35 2.47 2.83 3.04 4.98 5.15 1.00 0.00
Note & Lease Receivable		 - - - - - - - 0.00 0.00 0.00
Accounts Receivable		 71 94 104 231 178 131 119 69 66 74
Inventories, net		 28 38 71 128 187 196 148 85 57 73
Prepaid Expenses		 1.24 7.84 8.48 9.67 24 49 16 17 17 34
Plant, Property, & Equipment, net		 1.55 4.41 5.83 9.24 19 21 15 8.93 6.90 5.66
Total Noncurrent Assets		 15 22 53 103 146 317 319 310 268 265
Long-Term Investments		 11 13 30 58 68 244 245 239 226 220
Goodwill		 0.00 0.91 0.86 0.85 9.62 9.58 9.58 9.58 9.58 9.58
Intangible Assets		 0.18 0.82 9.27 12 22 21 18 9.87 7.09 14
Noncurrent Deferred & Refundable Income Taxes		 3.29 6.43 11 15 18 23 30 32 17 16
Other Noncurrent Operating Assets		 0.00 0.46 1.07 17 28 20 17 19 8.07 5.68
Total Liabilities & Shareholders' Equity		 140 225 474 743 908 955 764 636 529 565
Total Liabilities		 91 136 211 384 488 495 374 283 276 350
Total Current Liabilities		 91 135 202 356 429 338 242 155 195 287
Short-Term Debt		 0.38 0.80 2.76 0.31 0.00 16 66 69 62 112
Accounts Payable		 79 110 156 289 302 215 66 37 51 81
Accrued Expenses		 6.83 14 31 51 39 50 29 44 38 38
Current Deferred Revenue		 0.84 1.64 0.87 6.43 6.54 0.66 0.31 - 0.20 0.08
Current Deferred & Payable Income Tax Liabilities		 2.96 3.31 7.87 9.74 4.26 0.41 0.39 0.99 0.51 0.37
Other Current Liabilities		 1.43 4.60 2.91 0.00 78 56 80 3.71 44 56
Total Noncurrent Liabilities		 0.00 1.61 8.91 28 59 157 133 128 80 63
Long-Term Debt		 - - - 0.00 9.23 114 99 120 75 59
Capital Lease Obligations		 - - 0.00 11 18 11 4.59 3.20 2.01 1.10
Noncurrent Deferred & Payable Income Tax Liabilities		 0.00 0.38 0.72 0.78 3.44 4.22 5.15 4.17 3.12 2.67
Other Noncurrent Operating Liabilities		 0.00 0.76 8.19 16 28 27 24 0.27 0.13 0.21
Total Equity & Noncontrolling Interests		 4.33 35 263 359 420 460 389 353 253 215
Total Preferred & Common Equity		 4.33 35 264 359 420 458 387 351 252 215
Total Common Equity		 4.33 35 264 359 420 458 387 351 252 215
Common Stock		 7.30 11 200 212 239 258 245 273 278 281
Retained Earnings		 -5.23 20 49 131 174 199 137 104 29 -11
Treasury Stock		 - - - - 0.00 -3.42 -9.74 -13 -15 -16
Accumulated Other Comprehensive Income / (Loss)		 2.26 3.39 14 16 6.86 4.59 15 -14 -40 -39
Noncontrolling Interest		 0.00 0.37 -0.19 -0.45 0.00 2.05 1.80 1.87 1.14 0.00

Quarterly Balance Sheets for Zepp Health

No quarterly balance sheets for Zepp Health are available.

Annual Metrics And Ratios for Zepp Health

This table displays calculated financial ratios and metrics derived from Zepp Health's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
DEI Shares Outstanding		 0.00 0.00 280,208,957.00 241,679,772.00 247,519,987.00 250,145,163.00 251,201,159.00 245,338,687.00 240,827,151.00 231,984,611.00 234,886,003.00
DEI Adjusted Shares Outstanding		 0.00 0.00 70,052,239.00 60,419,943.00 61,879,997.00 62,536,291.00 62,800,290.00 61,334,672.00 60,206,788.00 231,984,611.00 234,886,003.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 0.10 0.27 1.33 0.56 0.34 -0.71 -0.52 -0.33 -0.17
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% 63.52% 40.87% 68.76% 57.28% 18.57% -0.88% -37.43% -42.50% -48.25% 41.78%
EBITDA Growth		 0.00% 174.21% 575.63% 87.61% 65.38% -66.39% -4.92% -259.04% 49.60% -125.71% 49.39%
EBIT Growth		 0.00% 167.87% 619.15% 88.18% 63.59% -70.13% -20.59% -361.39% 43.64% -86.13% 45.95%
NOPAT Growth		 0.00% 140.08% 1,294.95% 92.71% 66.46% -69.16% -43.95% -426.63% 50.77% -55.17% 38.14%
Net Income Growth		 0.00% 159.58% 646.74% 90.92% 68.17% -57.08% -39.17% -301.70% 28.28% -143.87% 47.15%
EPS Growth		 0.00% 81.97% 395.45% -21.54% 339.22% -60.71% -40.91% -301.70% 28.28% -123.08% 44.83%
Operating Cash Flow Growth		 0.00% 340.30% 1,377.19% 181.62% -40.34% -60.63% -250.76% -221.09% 136.38% -157.26% -5.33%
Free Cash Flow Firm Growth		 0.00% 0.00% 259.46% 131.73% -7.19% 9.58% -265.38% -17.18% 84.79% 634.67% -128.28%
Invested Capital Growth		 0.00% 0.00% 24.94% -5.43% 193.44% -48.31% 356.82% 41.79% -4.30% -67.60% 1.67%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 12.34% 17.74% 24.14% 25.77% 25.25% 20.71% 20.89% 19.37% 26.17% 38.46% 38.31%
EBITDA Margin		 -4.32% 1.96% 9.40% 10.45% 10.99% 3.11% 2.99% -7.60% -6.66% -29.03% -10.36%
Operating Margin		 -4.47% 0.86% 8.88% 10.03% 10.43% 2.71% 1.50% -10.08% -8.63% -25.88% -11.29%
EBIT Margin		 -4.35% 1.81% 9.22% 10.28% 10.69% 2.69% 2.16% -9.01% -8.84% -31.78% -12.12%
Profit (Net Income) Margin		 -4.22% 1.54% 8.16% 9.23% 9.86% 3.57% 2.19% -7.06% -8.81% -41.52% -15.48%
Tax Burden Percent		 97.69% 82.96% 87.07% 86.99% 87.89% 86.48% 128.39% 77.55% 89.77% 130.92% 112.99%
Interest Burden Percent		 99.35% 102.68% 101.59% 103.17% 104.97% 153.29% 79.09% 101.04% 111.07% 99.77% 113.05%
Effective Tax Rate		 0.00% 10.70% 14.39% 13.46% 11.94% 11.73% 10.07% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 0.00% 23.73% 147.13% 262.36% 228.36% 62.25% 18.39% -30.28% -12.99% -31.13% -39.03%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 13.64% 143.82% 260.54% 226.33% 58.93% 16.15% -30.27% -8.27% -9.38% -28.21%
Return on Net Nonoperating Assets (RNNOA)		 0.00% -9.58% -109.76% -234.55% -201.89% -53.18% -13.51% 20.08% 4.61% 6.09% 21.88%
Return on Equity (ROE)		 0.00% 14.15% 37.38% 27.81% 26.47% 9.08% 4.88% -10.20% -8.38% -25.04% -17.15%
Cash Return on Invested Capital (CROIC)		 0.00% -176.27% 124.96% 267.93% 130.03% 125.95% -109.77% -64.85% -8.60% 70.99% -40.69%
Operating Return on Assets (OROA)		 0.00% 2.89% 15.91% 15.60% 14.66% 3.23% 2.27% -6.44% -4.46% -9.97% -5.74%
Return on Assets (ROA)		 0.00% 2.46% 14.07% 14.00% 13.53% 4.28% 2.31% -5.04% -4.44% -13.02% -7.33%
Return on Common Equity (ROCE)		 0.00% 1.26% 10.62% 23.56% 26.50% 9.08% 4.87% -10.16% -8.34% -24.92% -17.11%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 79.35% 74.01% 18.57% 22.93% 8.41% 4.69% -11.19% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -4.28 1.71 24 46 77 24 13 -43 -21 -33 -20
NOPAT Margin		 -3.13% 0.77% 7.60% 8.68% 9.19% 2.39% 1.35% -7.06% -6.04% -18.11% -7.90%
Net Nonoperating Expense Percent (NNEP)		 0.00% 10.09% 3.31% 1.82% 2.03% 3.33% 2.24% -0.02% -4.72% -21.75% -10.82%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - -7.74% -3.91% -8.44% -5.29%
Cost of Revenue to Revenue		 87.66% 82.26% 75.86% 74.23% 74.75% 79.29% 79.11% 80.63% 73.83% 61.54% 61.69%
SG&A Expenses to Revenue		 7.81% 6.59% 5.61% 5.87% 4.27% 4.07% 4.13% 5.72% 7.59% 13.61% 11.31%
R&D to Revenue		 6.87% 8.50% 7.51% 7.22% 7.41% 8.36% 8.24% 12.60% 14.60% 25.28% 17.50%
Operating Expenses to Revenue		 16.81% 16.88% 15.26% 15.74% 14.82% 18.01% 19.39% 29.45% 34.80% 64.34% 49.60%
Earnings before Interest and Taxes (EBIT)		 -5.94 4.03 29 55 89 27 21 -55 -31 -58 -31
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -5.90 4.37 30 55 92 31 29 -47 -23 -53 -27
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 25.42 3.18 2.53 1.96 1.69 0.67 0.24 0.25 0.16 7.28
Price to Tangible Book Value (P/TBV)		 0.00 26.49 3.34 2.63 2.03 1.83 0.71 0.25 0.26 0.17 8.17
Price to Revenue (P/Rev)		 0.81 0.49 0.35 1.26 0.84 0.72 0.31 0.15 0.25 0.21 6.03
Price to Earnings (P/E)		 0.00 0.00 15.54 40.32 8.54 20.16 14.13 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.90% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 6.43% 2.48% 11.71% 4.96% 7.08% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 0.00 8.32 5.15 24.58 7.86 12.17 0.00 0.00 0.00 0.00 26.52
Enterprise Value to Revenue (EV/Rev)		 0.00 0.54 0.30 0.79 0.47 0.32 0.00 0.00 0.00 0.00 5.41
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 27.46 3.14 7.57 4.29 10.23 0.00 0.00 0.00 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 0.00 29.80 3.21 7.69 4.41 11.83 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 70.09 3.89 9.11 5.13 13.33 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 48.52 2.54 4.07 6.40 13.03 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 4.58 8.92 9.01 6.59 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.01 0.01 0.01 0.03 0.06 0.31 0.44 0.54 0.55 0.80
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.03 0.06 0.27 0.27 0.35 0.31 0.28
Financial Leverage		 0.00 -0.70 -0.76 -0.90 -0.89 -0.90 -0.84 -0.66 -0.56 -0.65 -0.78
Leverage Ratio		 0.00 2.87 2.66 1.99 1.96 2.12 2.12 2.02 1.89 1.92 2.34
Compound Leverage Factor		 0.00 2.95 2.70 2.05 2.05 3.25 1.67 2.04 2.09 1.92 2.65
Debt to Total Capital		 0.00% 0.78% 0.90% 1.04% 3.05% 6.06% 23.51% 30.39% 35.23% 35.47% 44.54%
Short-Term Debt to Total Capital		 0.00% 0.78% 0.90% 1.04% 0.08% 0.00% 2.71% 11.83% 12.61% 15.75% 28.88%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 2.96% 6.06% 20.81% 18.56% 22.62% 19.72% 15.66%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 90.37% 60.38% -0.07% -0.12% 0.00% 0.34% 0.32% 0.34% 0.29% 0.00%
Common Equity to Total Capital		 0.00% 8.85% 38.72% 99.04% 97.07% 93.94% 76.15% 69.29% 64.42% 64.24% 55.46%
Debt to EBITDA		 0.00 0.09 0.03 0.05 0.12 0.88 4.83 -3.65 -8.17 -2.62 -6.42
Net Debt to EBITDA		 0.00 -7.79 -2.41 -4.44 -3.36 -12.78 -11.67 4.73 8.19 3.75 5.99
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.12 0.88 4.27 -2.23 -5.25 -1.46 -2.26
Debt to NOPAT		 0.00 0.22 0.03 0.06 0.15 1.15 10.67 -3.93 -9.00 -4.20 -8.42
Net Debt to NOPAT		 0.00 -19.90 -2.97 -5.35 -4.02 -16.66 -25.80 5.10 9.02 6.01 7.85
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.14 1.15 9.45 -2.40 -5.78 -2.34 -2.96
Altman Z-Score		 0.00 2.65 2.78 4.08 3.31 2.74 2.11 1.25 1.11 0.27 2.94
Noncontrolling Interest Sharing Ratio		 0.00% 91.09% 71.59% 15.29% -0.10% -0.06% 0.23% 0.45% 0.49% 0.50% 0.24%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 1.36 1.48 2.06 1.77 1.73 1.83 1.77 2.04 1.29 1.02
Quick Ratio		 0.00 1.04 1.13 1.59 1.38 1.24 1.08 1.04 1.34 0.81 0.46
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -13 20 47 44 48 -79 -93 -14 75 -21
Operating Cash Flow to CapEx		 -232.46% 168.06% 1,119.47% 4,129.35% 1,248.68% 188.26% -533.90% -9,686.85% 0.00% -3,450.07% -6,554.08%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 13.75 -11.23 -10.98 -2.09 13.58 -3.74
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 6.95 -5.18 -13.87 6.31 -4.39 -4.51
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 3.26 -6.15 -14.01 6.31 -4.52 -4.58
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 1.60 1.73 1.52 1.37 1.20 1.05 0.71 0.50 0.31 0.47
Accounts Receivable Turnover		 0.00 3.14 3.81 5.36 4.98 4.83 6.35 4.92 3.75 2.71 3.72
Inventory Turnover		 0.00 6.66 7.24 7.24 6.27 4.97 4.05 2.87 2.24 1.59 2.47
Fixed Asset Turnover		 0.00 144.10 105.48 103.62 110.77 69.67 48.83 34.48 30.01 23.07 41.23
Accounts Payable Turnover		 0.00 2.34 2.53 2.96 2.80 2.65 3.00 3.52 5.03 2.54 2.42
Days Sales Outstanding (DSO)		 0.00 116.41 95.77 68.08 73.33 75.49 57.46 74.25 97.40 134.88 98.12
Days Inventory Outstanding (DIO)		 0.00 54.84 50.43 50.44 58.18 73.42 90.16 126.96 163.27 230.10 148.03
Days Payable Outstanding (DPO)		 0.00 156.10 144.15 123.40 130.40 137.51 121.47 103.56 72.50 143.51 150.66
Cash Conversion Cycle (CCC)		 0.00 15.15 2.05 -4.88 1.11 11.40 26.15 97.65 188.17 221.47 95.50
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 14 18 17 50 26 118 168 160 52 53
Invested Capital Turnover		 0.00 30.90 19.35 30.22 24.85 26.05 13.61 4.29 2.15 1.72 4.94
Increase / (Decrease) in Invested Capital		 0.00 14 3.60 -0.98 33 -24 92 49 -7.21 -108 0.87
Enterprise Value (EV)		 0.00 120 93 420 393 315 -35 -128 -103 -158 1,402
Market Capitalization		 110 110 110 666 702 709 305 91 87 39 1,562
Book Value per Share		 $0.00 $0.08 $0.51 $0.94 $1.49 $1.70 $1.83 $1.54 $1.43 $0.97 $0.84
Tangible Book Value per Share		 $0.00 $0.07 $0.49 $0.90 $1.43 $1.57 $1.71 $1.43 $1.35 $0.91 $0.75
Total Capital		 0.00 49 89 266 370 447 602 559 545 392 387
Total Debt		 0.00 0.38 0.80 2.76 11 27 142 170 192 139 172
Total Long-Term Debt		 0.00 0.00 0.00 0.00 11 27 125 104 123 77 61
Net Debt		 0.00 -34 -71 -246 -309 -394 -342 -221 -192 -199 -161
Capital Expenditures (CapEx)		 0.44 1.47 3.27 2.49 4.92 13 6.83 1.21 -0.01 0.71 0.39
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 9.43 6.15 -1.98 13 -39 56 107 85 6.14 5.47
Debt-free Net Working Capital (DFNWC)		 0.00 33 65 217 275 313 295 253 230 118 118
Net Working Capital (NWC)		 0.00 32 64 214 274 313 279 187 162 56 6.68
Net Nonoperating Expense (NNE)		 1.49 -1.72 -1.74 -2.89 -5.64 -12 -8.23 0.05 9.77 43 20
Net Nonoperating Obligations (NNO)		 0.00 -34 -71 -246 -309 -394 -342 -222 -192 -201 -162
Total Depreciation and Amortization (D&A)		 0.04 0.34 0.57 0.90 2.47 4.17 8.14 8.71 7.69 5.02 4.54
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 4.22% 1.96% -0.37% 1.58% -3.98% 5.66% 17.45% 24.00% 3.36% 2.11%
Debt-free Net Working Capital to Revenue		 0.00% 14.66% 20.66% 40.84% 32.91% 31.68% 30.12% 41.26% 65.27% 64.55% 45.73%
Net Working Capital to Revenue		 0.00% 14.49% 20.41% 40.32% 32.87% 31.68% 28.46% 30.48% 45.80% 30.78% 2.58%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.10 $0.08 $0.34 $0.92 $0.55 ($4.68) ($3.48) ($0.29) ($0.16)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 67.78M 211.87M 243.65M 248.47M 252.17M 61.57M 60.78M 258.88M 254.43M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.10 $0.07 $0.32 $0.88 $0.52 ($4.68) ($3.48) ($0.29) ($0.16)
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 76.29M 225.03M 255.96M 260.35M 264.37M 61.57M 60.78M 258.88M 254.43M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 280.21M 241.68M 247.52M 250.15M 251.20M 61.33M 60.21M 231.98M 234.89M
Normalized Net Operating Profit after Tax (NOPAT)		 -4.28 1.71 24 46 77 24 13 -43 -21 -33 -20
Normalized NOPAT Margin		 -3.13% 0.77% 7.60% 8.68% 9.19% 2.39% 1.35% -7.06% -6.04% -18.11% -7.90%
Pre Tax Income Margin		 -4.32% 1.85% 9.37% 10.61% 11.22% 4.13% 1.71% -9.11% -9.81% -31.71% -13.70%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 7.66 3.00 -6.55 -4.62 -10.45 -5.51
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 6.80 1.88 -5.13 -3.16 -5.96 -3.59
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 3.97 2.03 -6.69 -4.62 -10.58 -5.57
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 3.10 0.91 -5.27 -3.16 -6.08 -3.66
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.79% 0.00% 0.00% -14.55% 0.00% -0.93% -2.67%
Augmented Payout Ratio		 -51.43% 0.00% 0.00% 2.43% 0.79% 0.00% 10.05% -33.38% -8.91% -3.93% -5.76%

Quarterly Metrics And Ratios for Zepp Health

No quarterly metrics and ratios for Zepp Health are available.


Financials Breakdown Chart

Zepp Health Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Zepp Health's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Zepp Health's net income appears to be on a downward trend, with a most recent value of -$40.07 million in 2025, rising from -$5.76 million in 2015. The previous period was -$75.81 million in 2024. Find out what analysts predict for Zepp Health in the coming months.

Zepp Health's total operating income in 2025 was -$29.23 million, based on the following breakdown:
  • Total Gross Profit: $99.19 million
  • Total Operating Expenses: $128.42 million

Over the last 10 years, Zepp Health's total revenue changed from $136.48 million in 2015 to $258.90 million in 2025, a change of 89.7%.

Zepp Health's total liabilities were at $350.30 million at the end of 2025, a 27.0% increase from 2024, and a 285.1% increase since 2016.

In the past 9 years, Zepp Health's cash and equivalents has ranged from $21.96 million in 2016 to $349.65 million in 2020, and is currently $57.05 million as of their latest financial filing in 2025.

Over the last 10 years, Zepp Health's book value per share changed from 0.00 in 2015 to 0.84 in 2025, a change of 84.3%.


Related Companies

Financial statements for NYSE:ZEPP last updated on 7/16/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
The $15 Gold Fund That Pays Up to $1,152/Month
Gold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...
Investors Alley | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Elon’s new "tollbooth"
The SpaceX IPO was valued at $1.75 trillion. But one analyst says fighting over those shares may be the wrong ...
Weiss Ratings | Sponsoredtc pixel